Thirteen subjects with Type 2 diabetes mellitus were studied in a double-blind crossover design with 4-week placebo run-in and washout and 12-week treatment periods , randomised to micronised fenofibrate 267 mg or atorvastatin 10mg daily followed by the alternate drug in the second period .